Effect of MePEG molecular weight and particle size on in vitro release of tumor necrosis factor-alpha-loaded nanoparticles1
- 1 February 2005
- journal article
- Published by Springer Nature in Acta Pharmacologica Sinica
- Vol. 26 (2) , 242-249
- https://doi.org/10.1111/j.1745-7254.2005.00537.x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Stability and Release Performance of a Series of Pegylated Copolymeric MicellesPharmaceutical Research, 2003
- Nanoparticles in cancer therapy and diagnosisAdvanced Drug Delivery Reviews, 2002
- PLGA–mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood propertiesJournal of Controlled Release, 2002
- PEGylated polycyanoacrylate nanoparticles as tumor necrosis factor-α carriersJournal of Controlled Release, 2001
- PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in ratsPublished by Elsevier ,2001
- Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluationJournal of Controlled Release, 2001
- Stealth Polycyanoacrylate Nanoparticles as Tumor Necrosis Factor-.ALPHA. Carriers: Pharmacokinetics and Anti-tumor Effects.Biological & Pharmaceutical Bulletin, 2001
- Biodistribution of Long-Circulating PEG-Grafted Nanocapsules in Mice: Effects of PEG Chain Length and DensityPharmaceutical Research, 2001
- In vitro cell interaction and in vivo biodistribution of poly(lactide-co-glycolide) nanospheres surface modified by poloxamer and poloxamine copolymersJournal of Controlled Release, 1997
- In vitro model for the degradation of alkylcyanoacrylate nanoparticlesBiomaterials, 1990